1. Introduction {#sec1-antibiotics-07-00076}
===============

Nanotechnology has shown remarkable applications in biomedicine, diagnosis and antibacterial treatments, and is now transforming the agricultural sector, particularly with the development of novel nanopesticides and nanofertilizers \[[@B1-antibiotics-07-00076]\]. The increase in the frequency of resistant or tolerant pathogenic agents, which has in turn led to an excessive application of pesticides, has resulted in an increase in the presence of residues in food products, which may pose a major risk to health. The design and testing of safe, effective and environmentally sustainable formulations based on nanoemulsions, nanocomposites and nanoparticles to control agricultural pests and pathogens has become a burgeoning field of research in the past few years.

Silver, which has long been used as a disinfectant for pathogenic microorganisms \[[@B2-antibiotics-07-00076]\], has become one of the best exponents of this transition. Silver nanoparticles (AgNPs), which feature antibacterial, antifungal and antitumor activities \[[@B3-antibiotics-07-00076],[@B4-antibiotics-07-00076],[@B5-antibiotics-07-00076]\], are one of the most popular active ingredients employed to enhance the efficacy of plant protection products. Furthermore, they can be prepared through green synthesis procedures with the aid of plant extracts \[[@B6-antibiotics-07-00076]\], which act as reducing and stabilizing agents. Polyol components, polysaccharides, and water-soluble heterocycles (such as those from *Stevia rebaudiana* \[[@B7-antibiotics-07-00076]\], *Curcuma longa* \[[@B8-antibiotics-07-00076]\], *Pongamia pinnata* \[[@B9-antibiotics-07-00076]\], *Gliricidia sepium* \[[@B10-antibiotics-07-00076]\], *Eucalyptus hybrida* \[[@B11-antibiotics-07-00076]\], or *Quercus brantii* \[[@B12-antibiotics-07-00076]\]) have been reported to lead to a synergistic effect in the resulting phytonanocomposites \[[@B13-antibiotics-07-00076],[@B14-antibiotics-07-00076],[@B15-antibiotics-07-00076]\].

Nonetheless, bioactive compounds from plants (that include phenolic acids, flavonoids, curcuminoids, coumarins, quinones, tannins and lignans), in spite of having a wide range of activities, generally suffer from a number of drawbacks derived from their inherent physicochemical characteristics (poor water solubility, low bioavailability, chemical instability, photodegradation, rapid metabolism and short half-life) \[[@B16-antibiotics-07-00076]\], which limit their applications. To stabilize them and improve their bioavailability, one well-known approach is to use biopolymers, such as chitin, chitosan, starch, and cellulose, or other macromolecular systems \[[@B17-antibiotics-07-00076]\]. Binary composites based on chitosan with polyphenols (e.g., gallic acid or curcumin \[[@B18-antibiotics-07-00076],[@B19-antibiotics-07-00076],[@B20-antibiotics-07-00076]\]) and ternary composites that also include AgNPs \[[@B21-antibiotics-07-00076],[@B22-antibiotics-07-00076]\] with a broadened bio-activity have been reported in the literature.

Other approaches to improve solubility are based on forming inclusion compounds with terpene glycosides (such as rubusoside, stevioside, rebaudioside, or steviol monoside) or cyclodextrins, which result in an enhancement of the solubility of polyphenols \[[@B23-antibiotics-07-00076],[@B24-antibiotics-07-00076]\], or on using deep eutectic solvents (DES). DES are an excellent extraction medium for phenolic compounds \[[@B25-antibiotics-07-00076]\] and may be used in combination with inclusion compounds \[[@B26-antibiotics-07-00076]\] or with chitosan \[[@B27-antibiotics-07-00076],[@B28-antibiotics-07-00076]\].

*Phytophthora cinnamomi* is a pathogen with over 1000 host species, transmitted by the soil and which causes rotting of the roots of many horticultural and forestry crops \[[@B29-antibiotics-07-00076]\]. *P. cinnamomi* can collapse, which cause sudden death of plants and a decrease in fruit yield and size. The infection by *P. cinnamomi* can also occur together with other species of *Phytophthora*, mainly *P. cambivora*, *P. cryptogea*, *P. citricola* and *P. cactorum*. Its eradication by means of fungicides is expensive and causes damage to the environment, and fumigation is not always effective for deeper roots \[[@B30-antibiotics-07-00076],[@B31-antibiotics-07-00076]\]. Consequently, the European Union is promoting the development of new natural bioactive compounds to replace conventional systemic fungicides, such as the organophosphorus compound fosetyl-Al or acylalanines such as metalaxyl.

It has been shown, in vitro, that AgNPs synthesized using aqueous plant extracts have had antifungal effect on *Phytophthora* pathogens \[[@B32-antibiotics-07-00076]\], and so do chitosan \[[@B33-antibiotics-07-00076]\], the binary combinations of the two \[[@B34-antibiotics-07-00076]\] and their ternary combinations with propolis \[[@B35-antibiotics-07-00076]\]. Nonetheless, to the best of the authors' knowledge, no studies have explored the use of composites of AgNPs with polyphenol inclusion compounds, combined either with chitosan oligomers (COS) or with DES, for the control of *P. cinnamomi* or any other oomycetes.

In the present study, four polyphenols (gallic acid, silymarin, ferulic acid and curcumin) were assessed for the microwave-assisted formation of the new inclusion compounds with stevioside. AgNPs were subsequently incorporated into the composites \[[@B36-antibiotics-07-00076]\]. Two types of host matrices were tested, namely COS in a hydroalcoholic solution, and a DES based on a choline chloride and urea solution (1:2 *v/v*) in glycerol, evaluating in vitro their response against *P. cinnamomi* at different concentrations.

2. Results {#sec2-antibiotics-07-00076}
==========

The antifungal activity of the different treatments in aforementioned two preparation media (COS in hydroalcoholic solution and DES) against *P. cinnamomi* (isolate MYC43) was studied in vitro by monitoring the radial growth of the mycelium ([Figure 1](#antibiotics-07-00076-f001){ref-type="fig"} and [Figure 2](#antibiotics-07-00076-f002){ref-type="fig"}).

As shown in [Figure 3](#antibiotics-07-00076-f003){ref-type="fig"}, the increase in the concentration of the inclusion complexes from 125 µg·mL^−1^ to 500 µg·mL^−1^ resulted in a reduction in the radial growth of the mycelium in all cases. It may be observed that 100% mycelial growth inhibition occurred with the COS medium at the highest concentration of 500 µg·mL^−1^ for the composites with gallic acid, ferulic acid and curcumin (but not for silymarin). On the other hand, at lower concentrations (125 and 250 µg·mL^−1^), silymarin and ferulic acid-based treatments were more effective than those based on gallic acid and curcumin.

As regards the nanocomposites with a DES preparation medium, total inhibitory activities were attained for the composites based on the four polyphenols under study concentrations of 250, and 500 µg·mL^−1^. Further, at the lowest concentration of 125 µg·mL^−1^, the antifungal performance of the composites in the DES medium was close to 90% for all polyphenols. Thus, the product efficacies were clearly higher than those of the composites based on the hydroalcoholic solution of COS.

Upon comparison with the treatments without phenolic inclusion compounds, it could be observed that the AgNPs-only treatment attained a lower inhibition than the composites for the COS medium, with mycelium growth even at the highest dose. On the other hand, the DES-based AgNPs-only treatment performed noticeably better than its COS counterpart, albeit it did not completely inhibit growth at a concentration of 250 mg·mL^−1^ (whereas all the composites did). Therefore, an enhanced fungal growth control activity of the ternary mixtures was evidenced.

The results from the sensitivity tests for *P. cinnamomi* may also be expressed with the help of EC~50~ and EC~90~ indicators ([Table 1](#antibiotics-07-00076-t001){ref-type="table"}). The sensitivity of the isolate mainly varied as a function of the preparation media, but also according to the phenolic compound used. In line with the discussion presented above, *P. cinnamomi* (MYC43) was found to be remarkably more sensitive to the treatments prepared in DES, with EC~50~ values ranging from 0.1 to 8.9 µg·mL^−1^ and EC~90~ values between 77.9 and 184.3 µg·mL^−1^. For comparison purposes, for the COS in hydroalcoholic solution medium treatments the EC~50~ values ranged from 171.6 to 279.9 µg·mL^−1^ and those of EC~90~ from 450.4 to 963.7 µg·mL^−1^.

The highest sensitivity of the *P. cinnamomi* isolate (MYC43) corresponded to the inclusion compound with gallic acid in DES (EC~50~ = 0.1 µg·mL^−1^), followed by the inclusion compounds with silymarin and ferulic acid, and finally by the one with curcumin, with EC~50~ values of 0.6, 0.6 and 8.9 µg·mL^−1^, respectively.

3. Discussion {#sec3-antibiotics-07-00076}
=============

With a view to comparing the efficacy of the proposed nanocomposites verses other phenolic-based products against *Phytophthora* spp. discussed in the literature, it should be noted that Kim et al. \[[@B37-antibiotics-07-00076]\] reported strong fungicidal activities of *Curcuma longa* L. rhizome-derived curcumin in ethyl acetate and hexane fractions against *P. infestans* with 100% and 84% control values at a concentration of 1000 µg·mL^−1^. Apart from the higher concentrations used in those experiments as compared to the ones presented herein, it should be noted that a contribution of the pronounced cytotoxic activities of the solvents could not be excluded.

Pompimon et al. \[[@B38-antibiotics-07-00076]\] assessed the anti-*P. capsici* activity of *C. longa* in acetone fraction, finding an inhibition of mycelial growth of ca. 90% at a concentration of 300 µg·mL^−1^, higher than the EC~90~ of 184 µg·mL^−1^ of the curcumin-based treatment in DES media reported in this study.

The nanocomposites of the four polyphenols in DES medium would also be more active than, for instance, cuminic acid, which featured an EC~50~ value against mycelial growth of *P. capsici* of 19.7 µg·mL^−1^ (which in turn was lower than the EC~50~ value of other benzoic acid derivatives in previous reports) \[[@B39-antibiotics-07-00076]\]. Other natural compounds, such as furanocoumarins (e.g., psoralen or isopsoralen) would require concentrations of 500 µg·mL^−1^ to attain 82--84% disease control against *P. infestans* \[[@B40-antibiotics-07-00076]\].

An EC~50~ value of amphopolycarboxyglycinate-stabilized AgNPs against *P. infestans* of 3.1 µg·mL^−1^ was reported by Krutyakov et al. \[[@B41-antibiotics-07-00076]\], i.e., a 30 and 6 times higher concentration than those obtained for the AgNPs combined with gallic acid, silymarin and ferulic acid inclusion compounds in DES, respectively.

Banik and Pérez-de-Luque \[[@B42-antibiotics-07-00076]\] found that the integration of copper nanoparticles (CuNPs) with non-nano copper like copper oxychloride, both at a 50 µg·mL^−1^ concentration, resulted in a 76% growth inhibition in vitro of the oomycete *P. cinnamomi* as compared to the control. Since in comparative assays between NPs the concentrations of AgNPs are usually 10 times higher than those CuNPs \[[@B43-antibiotics-07-00076],[@B44-antibiotics-07-00076]\], the equivalent concentration of AgNPs to attain aforementioned effects should be 500 ca. µg·mL^−1^, four times higher than that required by the DES treatments to attain a comparable mycelial growth inhibition (ca. 90%).

Chitosan has also been assayed against *P. infestans* \[[@B33-antibiotics-07-00076]\], finding that concentrations of 500 µg·mL^−1^ would be required to fully inhibit mycelial growth, similar to those of the COS-based nanocomposites with gallic acid, ferulic acid and curcumin in this study. On the other hand, *N*-(6-carboxyl cyclohex-3-ene carbonyl) chitosan with different degrees of substitution achieved an EC~50~ of 298 µg·mL^−1^ for *P. infestans* \[[@B45-antibiotics-07-00076]\], better than the ones for the COS composites based on the three aforementioned polyphenols (in the 450--490 µg·mL^−1^ range).

The overall efficacy of the reported nanocomposites should be referred to the combination of the properties afforded by each of its constituents and their synergies.

According to Kim et al. \[[@B46-antibiotics-07-00076]\], nanosilver may exert an antifungal activity by disrupting the structure of the cell membrane and inhibiting the normal budding process due to the destruction of the membrane integrity. Silver nanoparticles antifungal action may also result from the release of silver ions into the intracellular matrix of the pathogen \[[@B47-antibiotics-07-00076]\]. Reports on the mechanism of inhibitory action of silver ions on microorganisms have shown that upon treatment with Ag^+^, DNA loses its ability to replicate, resulting in inactivated expression of ribosomal subunit proteins, as well as certain other cellular proteins and enzymes essential to ATP production. It has also been hypothesized that Ag^+^ would affect the function of membrane-bound enzymes, such as those in the respiratory chain \[[@B4-antibiotics-07-00076]\].

Apropos of the role of the stevioside, the improvement in the solubility and bioavailability of the polyphenolic compounds should be ascribed to the formation of a nanocomposite structure comprising a transglycosylated compound, which includes the insoluble compounds. Transglycosylated materials have been reported to self-associate into particular micelle-like structures with a core-shell-like architecture, in which the hydrophobic skeleton is segregated from the aqueous exterior to form a novel drug-loading core, surrounded by a hydrophilic shell of sugar groups \[[@B48-antibiotics-07-00076]\]. For instance, Kadota, Okamoto, Sato, Onoue, Otsu and Tozuka \[[@B24-antibiotics-07-00076]\] found a 13000× increase in curcumin solubility when the tri-component system curcumin/*α*-glucosyl stevia/polyvinylpyrrolidone was used.

In relation to the phenolic compounds, they have been reported to have toxic activities against fungi involved in the deterioration of agricultural products by interfering with the development of mycelia \[[@B49-antibiotics-07-00076]\]. They affect membrane functions such as electron transport, nutrition, enzyme activity, protein and nucleic acid synthesis, and they interact with membrane proteins, causing disruption of the structures and functionality. For instance, curcumin's efficacy would be influenced by its lipophilic nature, which leads to an adequate transmembrane permeability \[[@B16-antibiotics-07-00076]\]. Its antifungal mechanism has been ascribed to the disruption of plasma membrane integrity, causing leakage of potassium ion from the cytosol and change in membrane potential \[[@B50-antibiotics-07-00076]\]. On the other hand, gallic acid would exhibit both antioxidant as well as pro-oxidant characteristics, displaying a dual-edge sword behavior, which turns it into an efficient apoptosis inducing agent \[[@B51-antibiotics-07-00076]\].

Regarding the inhibition mode of chitosan, three mechanisms have been proposed \[[@B52-antibiotics-07-00076]\]: (1) Its positive charge can interact with negatively charged phospholipid components of fungi membrane, increasing its permeability and causing the leakage of cellular contents, which subsequently leads to cell death; (2) it can act as a chelating agent by binding to trace elements, causing the essential nutrients unavailable for normal growth of fungi; and (3) it may be able to penetrate the cell wall of fungi and bind to its DNA, inhibiting the synthesis of mRNA and, thus, affecting the production of essential proteins and enzymes.

As far as DES are concerned, they would act as a plasticizer, affecting the apparent viscosity of the solutions and enhancing water vapor permeability, water solubility and water sorption capability, as reported by Almeida, Magalhães, Souza and Gonçalves \[[@B27-antibiotics-07-00076]\]. Nonetheless, it worth noting that, while choline chloride and urea show no inhibition as individual materials, their final product as ChCl:U DES has been reported to show inhibition towards *Candida cylindracea* \[[@B53-antibiotics-07-00076]\]. This behavior could be due to the synergistic effect of forming DES \[[@B54-antibiotics-07-00076]\] and can be used to prove that occasionally DES have a higher toxicological behavior than its original components.

The antimicrobial activity of DES is still not fully understood \[[@B55-antibiotics-07-00076]\]. Some reports have noted that DES would increase the permeability of the lipid membrane of eukaryotic cells \[[@B56-antibiotics-07-00076],[@B57-antibiotics-07-00076]\], as chitosan does. Since the mechanism for COS and DES would tentatively be similar, the differences in the performance of the composites presented herein in terms of fungal growth control should then be ascribed to differences in their ability to solubilize a wide range of solutes (e.g., components in the fungal cell membrane), pH, osmolality or chelation of membrane-bound divalent cations \[[@B58-antibiotics-07-00076]\].

Since one of the possible mechanisms of action of silver requires that the silver ions enter the fungal cell for efficient killing, the enhancement of permeability driven by COS, DES and polyphenols would support that their interaction should be synergistic rather than simply additive.

From our work, the best results of mycelial growth inhibition at the lowest concentration (125 mg·mL^−1^) in DES (GI 91.5%), attained for the composite based on gallic acid, may be ascribed to the fact that gallic acid is extremely well absorbed, and very soluble in water as compared with other polyphenols \[[@B51-antibiotics-07-00076]\]. Moreover, the introduction of the hydroxyl group on the cation in the chloride of choline salt has also been reported to significantly improve the extraction capacity of ionic liquids for gallic acid \[[@B59-antibiotics-07-00076]\].

4. Materials and Methods {#sec4-antibiotics-07-00076}
========================

4.1. Reagents {#sec4dot1-antibiotics-07-00076}
-------------

Stevioside standard was purchased from Wako (Osaka, Japan). Gallic acid, silymarin, ferulic acid, curcumin, choline chloride, urea, glycerol, and silver nanoparticles (40 nm particle size (TEM), 0.02 mg·mL^−1^ in aqueous buffer, with sodium citrate as a stabilizer) were purchased from Sigma-Aldrich/Merck KGaA (Darmstadt, Germany).

Chitosan oligomers were obtained from medium molecular weight chitosan (supplied by Hangzhou Simit Chemical Technology Co., Ltd., Hangzhou, China), dissolving 10 g in 500 mL of acetic acid (1%) under constant stirring at 60 °C. Once dissolved, hydrogen peroxide (0.3 mol·L^−1^) was added for the degradation of the polymer chains, obtaining oligomers of less than 2000 Da \[[@B60-antibiotics-07-00076]\].

Liquefaction of the choline chloride and urea (1:2 *v/v*) eutectic mixture occurred at 80 °C under stirring in a hot-plate magnetic stirrer for 10 min, in good agreement with Biswas et al. \[[@B61-antibiotics-07-00076]\].

4.2. Microwave-Assisted Preparation of the Polyphenol Inclusion Compounds {#sec4dot2-antibiotics-07-00076}
-------------------------------------------------------------------------

The aqueous biphasic system separation technique was used for the formation of the inclusion compounds. This technology is a liquid-liquid extraction system for bioseparation and is frequently used to process all types of biotechnological materials, such as proteins, enzymes, phytochemicals, nucleic acids and pigments \[[@B62-antibiotics-07-00076]\]. In the case under study, the inclusion complexes formed with stevioside were recovered from the upper part of the reactor.

4.3. Chitosan Oligomers (COS)-Based Composites {#sec4dot3-antibiotics-07-00076}
----------------------------------------------

In each of the four jars with screw caps, 1 g of chitosan oligomers of 2000 Da (COS), 0.06 g of stevioside and 0.01 g of one of the polyphenols (either gallic acid, silymarin, ferulic acid or curcumin) were added to 40 mL of hydroalcoholic solution (1:1 *v/v* distilled water and ethanol), followed by treatment in a microwave (Milestone Ethos-One, Sorisole, BG, Italy) at 80 °C for 20 min under stirring. The resulting solutions were centrifuged at 2500 rpm and stored at 4 °C. For the incorporation of the silver nanoparticles to the nanocomposite, 0.1 mL of commercial AgNPs (0.02 mg·mL^−1^) were added dropwise to 0.9 mL of the previously centrifuged microwave fractions, and the final solution (with pH 7.5) was stirred at room temperature.

4.4. Deep Eutectic Solvent-Based Composites {#sec4dot4-antibiotics-07-00076}
-------------------------------------------

To prepare the DES-based composites, 20 mL of choline chloride and urea (1:2 *v/v*) DES and 10 mL of glycerol were added to each of the four jars with screw caps, together with 0.03 g of stevioside and 0.01 g of the respective polyphenol (gallic acid, silymarin, ferulic acid or curcumin). The mixture was heated at 80 °C in the microwave, under stirring, for 20 min. Then, 0.1 mL of AgNPs (0.02 mg·mL^−1^) were added dropwise to 0.9 mL of the microwave fractions (previously centrifuged at 2500 rpm). The mixture, with pH 7.5, was subjected to vigorous stirring for 5 min at room temperature.

4.5. Silver Nanoparticles-Only Treatments {#sec4dot5-antibiotics-07-00076}
-----------------------------------------

Two additional treatments consisting of 0.1 mL of AgNPs (0.02 mg·mL^−1^) added dropwise to 0.9 mL of the dispersion medium (either COS or DES), without the polyphenol inclusion compounds, were prepared for control purposes. The mixtures were vigorously stirred for 5 min at room temperature.

4.6. Characterization of the Nanocomposites {#sec4dot6-antibiotics-07-00076}
-------------------------------------------

The structure and properties of the nanocomposites obtained through the synthetic procedures described above were characterized using Fourier-Transform Infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Results were recently reported in patent P201731489 \[[@B36-antibiotics-07-00076]\].

4.7. Fungal Isolates and Growth Conditions {#sec4dot7-antibiotics-07-00076}
------------------------------------------

The fungal species used in the experiment was *Phytophthora cinnamomi* isolate MYC43, supplied by Centro de Investigaciones Científicas y Tecnológicas de Extremadura---Instituto del Corcho, la Madera y el Carbón Vegetal, Spain. The isolate was maintained in potato-dextrose-agar (PDA) slant tubes, supplied by Merck Millipore (Darmstadt, Germany), stored at 4 °C.

4.8. Efficacy of the Nanocomposites for the Control of Phytophthora cinnamomi {#sec4dot8-antibiotics-07-00076}
-----------------------------------------------------------------------------

Agar disks (8 mm in diameter) were cut from the margin of a 7-day-old colony growing on PDA and were transferred to a PDA medium supplemented with the nanocomposites at final concentrations of 125 µg·mL^−1^, 250 µg·mL^−1^ and 500 µg·mL^−1^. Three replicates were performed for each treatment. For each active ingredient and concentration, inhibition of radial mycelial growth (mm) compared with the untreated control was evaluated after 7 days of incubation at 24 °C, in the dark. The relative growth inhibition (%) of each treatment compared to untreated control was calculated as follows: Growth inhibition (%) = \[(*dc* − *dt*)/*dc*\] × 100, where *dc* stands for the average diameter of the fungal colony in the control and *dt* is the average diameter of the treated colony \[[@B63-antibiotics-07-00076]\]. Results were expressed as effective concentrations EC~50~ and EC~90~ (i.e., the concentrations which reduced growth inhibition by 50% and 90%) by regressing the inhibition of radial mycelial growth values (% control) against the values of the antifungal nanocomposite concentrations.

5. Conclusions {#sec5-antibiotics-07-00076}
==============

Composites consisting of silver nanoparticles and polyphenol inclusion compounds were synthesized using two preparation media, one based on chitosan oligomers in an hydroalcoholic solution and the other based on a deep eutectic solvent. Both types of composites showed an increase in the water solubility of the polyphenols and in the in vitro antifungal activity against *Phytophthora cinnamomi* (MYC43 isolate). Nonetheless, the DES-based samples efficacy was remarkably higher than that of their counterparts with a chitosan oligomers-based matrix: Complete inhibition of mycelial growth was attained at concentrations of 250 and 500 µg·mL^−1^, and even at the lowest dose of 125 µg·mL^−1^, they resulted in a 90% growth inhibition. As regards the impact of the choice of the different polyphenols, for the DES-based treatments, the highest sensitivity of *P. cinnamomi* corresponded to the composite with gallic acid (EC~50~ = 0.1 µg·mL^−1^), followed by those with silymarin and ferulic acid, and finally by the one with curcumin, with EC~50~ values of 0.6, 0.6 and 8.9 µg·mL^−1^, respectively. This may be ascribed to the fact that gallic acid is extremely well absorbed, and very soluble in water as compared with other polyphenols. The reported activities for the composites were remarkably higher than those reported for *Phytophthora* spp. using AgNPs, chitosan or polyphenols separately. This points to the possibility of a successful application of these nanocomposites in agriculture, with the aim of reducing the use of toxic and expensive conventional systemic fungicides. Further research on the ability of the prepared nanocomposites to inhibit growth of *P. cinnamomi* in the context of a plant infection model and on the basic mechanism involved, fungistatic or fungicidal, is underway.

6. Patents {#sec6-antibiotics-07-00076}
==========

The work reported in this manuscript is related to Spanish patent P201731489.
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![*Phytophthora cinnamomi* growth inhibition assays with the nanocomposites based on the chitosan oligomers in hydroalcoholic solution preparation medium. *From left to right*: Control (no treatment) and treatments with AgNPs combined with gallic acid, silymarin, ferulic acid and curcumin inclusion compounds. *From top to bottom*: 125 µg·mL^−1^, 250 µg·mL^−1^, and 500 µg·mL^−1^ concentrations. Only one repetition per treatment is shown.](antibiotics-07-00076-g001){#antibiotics-07-00076-f001}

![*P. cinnamomi* growth inhibition assays with the nanocomposites based on the deep eutectic solvent preparation medium. *From left to right*: Control (no treatment) and treatments with AgNPs combined with gallic acid, silymarin, ferulic acid and curcumin inclusion compounds. *From top to bottom*: 125 µg·mL^−1^, 250 µg·mL^−1^ and 500 µg·mL^−1^ concentrations. Only one repetition per treatment is shown. The blue background in the control and curcumin-treated samples is due to the blue color of the paper on which the plates were on.](antibiotics-07-00076-g002){#antibiotics-07-00076-f002}

![Radial growth values of *P. cinnamomi* in the presence of the composites, which consisted of different polyphenol inclusion compounds and silver nanoparticles at different concentrations, either in a chitosan hydroalcoholic solution (COS) or in a deep eutectic solvent (DES). A control (no treatment) and two treatments with AgNPs (in COS and DES) without the inclusion compounds are shown for comparison purposes. Error bars represent the standard deviation across three replicates.](antibiotics-07-00076-g003){#antibiotics-07-00076-f003}
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Effective concentrations that inhibited mycelial growth by 50% and 90% (EC~50~ and EC~90~, respectively).

  Treatment          EC~50~ (µg·mL^−1^)   EC~90~ (µg·mL^−1^)
  ------------------ -------------------- --------------------
  COS AgNPs          458.4                1192.8
  COS Gallic acid    261.3                455.6
  COS Silymarin      261.8                963.7
  COS Ferulic acid   171.6                450.4
  COS Curcumin       279.9                487.4
  DES AgNPs          13.3                 253.3
  DES Gallic acid    0.1                  77.9
  DES Silymarin      0.6                  107.8
  DES Ferulic acid   0.6                  107.8
  DES Curcumin       8.9                  184.3
